Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis

Abstract Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods An international database of patients with OMD treated with SBRT was assembled with rigorous quali...

Full description

Bibliographic Details
Main Authors: Xuguang Chen, Hanbo Chen, Ian Poon, Darby Erler, Serena Badellino, Tithi Biswas, Roi Dagan, Matthew Foote, Alexander V. Louie, Umberto Ricardi, Arjun Sahgal, Kristin J. Redmond
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Cancer Medicine
Subjects:
late metastasis
metastasis‐directed radiotherapy
oligometastasis
SABR
SBRT
wide‐spread progression
Online Access:https://doi.org/10.1002/cam4.4133

Internet

https://doi.org/10.1002/cam4.4133

Similar Items